Neonatal liver failure

Seminars in Neonatology

Volumn 8, Issue 5, 2003, Pages 393-401

  McClean, Patricia ^a   Davison, Suzanne M ^a  

^a University Hospital   (United Kingdom)

Author keywords

Hepatopathy; Mitochondrial; Neonatal haemochromatosis; Neonatal liver failure; Viral hepatitis

Indexed keywords

ACETYLCYSTEINE; ACICLOVIR; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; CIDOFOVIR; FAMCICLOVIR; FOSCARNET; PENCICLOVIR; RANITIDINE; VITAMIN K GROUP;

DISORDERS OF MITOCHONDRIAL FUNCTIONS; EARLY DIAGNOSIS; HEMOCHROMATOSIS; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; MEDICAL DECISION MAKING; METABOLIC DISORDER; MORTALITY; NEWBORN; NEWBORN PERIOD; PATIENT REFERRAL; REVIEW; SIDE EFFECT; TREATMENT CONTRAINDICATION; VIRUS HEPATITIS;

EID: 0141963411     PISSN: 10842756     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1084-2756(03)00095-2     Document Type: Review

References (53)

1. Shneider BL. Neonatal liver failure. Curr Opin Pediatr 1996;8:495-501.
2. Durand P, Debray D, Mandel R et al. Acute liver failure in infancy: a 14-year experience of a pediatric liver transplantation center. J Pediatr 2001;130:871-6.
3. Aw MM, Rela M, Heaton ND et al. Neonatal liver failure-a ten year experience [abst]. J Pediatr Gastroenterol Nutr 2001;32:381A.
4. Harrison PM, Wendon JA, Gimson AE et al. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 1991;324:1852-7.
5. Ahola T, Fellman V, Laaksonen R et al. Pharmacokinetics of intravenous N-acetylcysteine in pre-term newborn infants. Eur J Clin Pharmacol 1999;55:645-50.
6. Singer AL, Olthoff KM, Kim H et al. Rote of plasmapheresis in the management of acute hepatic failure in children. Ann Surg 2001;234:418-24.
7. Stange J, Mitzner S, Risler T et al. Molecular adsorbent recycling system (MARS). Clinical results of a new membrane based blood purification system for bioartificial liver support. Artif Organs 1999;23:319-30.
8. Bonatti H, Muiesan P, Connelly S et al. Hepatic transplantation in children under 3 months of age: a single centre's experience. J Pediatr Surg 1997;32:486-8.
9. Noujaim HM, Mayer DA, Buckels JA et al. Techniques for and outcome of liver transplantation in neonates and infants weighing up to 5 kilograms. J Pediatr Surg 2002;37:159-64.
10. Wang J, Atchison RW, Walpusk J et al. Echovirus hepatic failure in infancy: report of four cases with speculation on the pathogenesis. Pediatr Dev Pathol 2001;4:454-60.
11. Modlin JF. Perinatal echovirus infection: insight from a literature review of 61 cases of serious infection and 16 outbreaks in nurseries. Rev Infect Dis 1986;8:918-26.
12. Sawyer MH. Enterovirus infections: diagnosis and treatment. Pediatr Infect Dis J 1999;18:1033-40.
13. Aradottir E, Alonso EM, Shulman ST. Severe neonatal enteroviral hepatitis treated with pleconaril. Pediatr Infect Dis J 2001;20:457-9.
14. Brown Z, Wald A, Morrow R et al. Effect of serologic status and Caesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003;289:203-9.
15. Kimberlin DW, Lin CY, Jacobs RF et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 2001;108:223-9.
16. Kimberlin DW, Lin CY, Jacobs RF et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 2001;108:230-8.
17. Bacon TH, Levin MJ, Leary JJ et al. Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy. Clin Microbiol Rev 2003;16:114-28.
18. Oram RJ, Marcellino D, Strauss D et al. Characterization of an acyclovir-resistant herpes simplex virus type 2 strain isolated from a premature neonate. J Infect Dis 2000;181:1458-61.
19. Levin MJ, Weinberg A, Leary JJ et al. Development of acyclovir resistant herpes simplex virus early during the treatment of herpes neonatorum. Pediatr Infect Dis J 2001;20:1094-7.
20. Kleymann G, Fischer R, Betz UA et al. New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease. Nat Med 2002;8:392-8.
21. Kao JH, Hsu HM, Shau WY et al. Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan. J Paediatr 2001;139:349-52.
22. Van Damme P, Vorsters A. Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001. J Med Virol 2002;67:433-9.
23. Santantonio T, Mazzola M, Pastore G. Lamivudine is safe and effective in fulminant hepatitis B. J Hepatol 1999;30:551.
24. Moodley D, Pillay K, Naidoo K et al. Pharmacokinetics of zidovudine and lamivudine in neonates following coadministration of oral doses every 12 hours. J Clin Pharmacol 2001;41:732-41.
25. Mendel I, de Matteis M, Bertin C et al. Fulminant hepatitis in neonates with human herpesvirus 6 infection. Pediatr Infect Dis J 1995;14:993-7.
26. Tokimasa S, Hara J, Osugi Y et al. Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation. Bone Marrow Transplant 2002;29:595-8.
27. Manichanh C, Olivier-Aubron C, Lagarde JP et al. Selection of the same mutation in the U69 protein kinase gene of human herpesvirus-6 after prolonged exposure to ganciclovir in vitro and in vivo. J Gen Virol 2001;82:2767-76.
28. Ilona LF, Pia O, Marianne F et al. Detection of herpes simplex virus DNA in dried blood spots making a retrospective diagnosis possible. J Clin Virol 2003;26:39-48.
29. Barbi M, Binda S, Primache V et al. Use of Guthrie cards for the early diagnosis of neonatal herpes simplex virus disease. Pediatr Infect Dis J 1998;17:251-2.
30. Kelly AL, Lunt PW, Rodrigues F et al. Classification and genetic features of neonatal haemochromatosis: a study of 27 affected pedigrees and molecular analysis of genes implicated in iron metabolism. J Med Genet 2001;38:599-610.
31. De Boissien D, Knisely AS. Neonatal hemochromatosis. Suchy FJ, Sokol RJ, Balistreri WF, editors. Liver disease in children. Philadelphia: Lippincott, Williams and Wilkins, 2001;641-7.
32. Siafakas CG, Jonas MM, Peraz-Atayde AR. Abnormal bite acid metabolism and neonatal hemochromatosis: a subset with poor prognosis. J Pediatr Gastroenterol Nutr 1997;25:321-6.
33. Lee WS, McKiernan PJ, Kelly DA. Serum ferritin level in neonatal fulminant liver failure [letter]. Arch Dis Child Fetal Neonatal Ed 2001;85:F226.
34. Vohra P, Haller C, Emre S et al. Neonatal hemochromatosis: the importance of early recognition of liver failure. J Pediatr 2000;136:537-41.
35. Sigurdsson L, Reyes J, Kocoshis SA et al. Neonatal hemochromatosis: outcomes of pharmacologic and surgical therapies. J Pediatr Gastroenterol Nutr 1998;26:85-9.
36. Knisety AS, O'Shea PA, Stocks JF et al. Oropharngeal and upper respiratory tract mucosal-gland siderosis in neonatal hemochromatosis: an approach to biopsy diagnosis. J Pediatr 1988;113:871-4.
37. Hayes AM, Jaramillo D, Levy HL et al. Neonatal hemochromatosis: diagnosis with MR imaging. Am J Roentgenol 1992;159:623-5.
38. Shamieh I, Kibort PK, Suchy FJ et at. Antioxidant therapy for neonatal iron storage disease [abst]. Pediatr Res 1993;33:109A.
39. Flynn DM, Mohan N, McKiernan P et al. Progress in treatment and outcome for children with neonatal haemochromatosis. Arch Dis Child Fetal Neonatal Ed 2003;88:F124-7.
40. Cormier-Daire V, Chretien D, Rustin P et al. Neonatal and delayed-onset liver involvement in disorders of oxidative phosphorylation. J Pediatr 1997;130:817-22.
41. Goncalves I, Hermans D, Chretien D et al. Mitochondrial respiratory chain defect: a new etiology for neonatal cholestasis and early liver insufficiency. J Hepatol 1995;23:290-4.
42. Munnich A, Rotig A, Chretien D et al. Clinical presentations and laboratory investigations in respiratory chain deficiency. Eur J Pediatr 1996;155:262-74.
43. Thompson M, McKiernan P, Buckets J et al. Generalised mitochondrial cytopathy is an absolute contraindication to orthotopic liver transplant in childhood. J Pediatr Gastroenterol Nutr 1998;26:478-81.
44. Dubern B, Broue P, Dubuisson C et al. Orthotopic liver transplantation for mitochondrial respiratory chain disorders: a study of 5 children. Transplantation 2001;71:633-7.
45. Rotig A, Bessis J-L, Romero N et al. Maternally inherited duplication of the mitochondrial genome in a syndrome of proximal tubulopathy, diabetes mellitus and cerebellar ataxia. Am J Hum Genet 1992;50:364-70.
46. Bakker HD, Scholte HR, Dingemans KP, et al. Depletion of mitochondrial deoxyribonucleic acid in a family with fatal neonatal liver disease. J Pediatr 1996;128:683-7.
47. Croffie JM, Gupta SK, Chung SKF et al. Tyrosinemia type 1 should be suspected in infants with severe coagulopathy even in the absence of other signs of liver failure. Pediatrics 1999;103:675-8.
48. Holme E, Lindstedt S. Nontransplant treatment of tyrosinemia. Clin Liver Dis 2000;4:805-14.
49. Mohan N, McKiernan P, Preece MA et al. Indications and outcome of liver transplantation in tyrosinaemia type 1. Eur J Pediatr 1999;158(Suppl 2):S49-54.
50. Parizhskaya M, Reyes J, Jaffe R. Hemophagocytic syndrome presenting as acute hepatic failure in two infants: clinical overlap with neonatal hemochromatosis. Pediatr Develop Pathol 1999;2:360-6.
51. Sung L, King SM, Carcao M et al. Adverse outcomes in primary hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol 2002;24:550-4.
52. Arico M, Janka G, Fischer A et al. Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. Leukaemia 1996;10:197-203.
53. Williams MD, Chalmers EA, Gibson BES. The investigation and management of neonatal haemostasis and thrombosis. Br J Haematol 2002;119:295-309.